- Home
- VRA vs CRVO Comparison
VRA vs CRVO Comparison
Compare VRA & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- CRVO
- Stock Information
- Founded
- VRA 1982
- CRVO 2001
- Country
- VRA United States
- CRVO United States
- Employees
- VRA N/A
- CRVO N/A
- Industry
- VRA Apparel
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- CRVO Health Care
- Exchange
- VRA Nasdaq
- CRVO Nasdaq
- Market Cap
- VRA 102.9M
- CRVO 98.3M
- IPO Year
- VRA 2010
- CRVO N/A
- Fundamental
- Price
- VRA $3.72
- CRVO $2.13
- Analyst Decision
- VRA Strong Buy
- CRVO Buy
- Analyst Count
- VRA 1
- CRVO 8
- Target Price
- VRA $5.50
- CRVO $38.75
- AVG Volume (30 Days)
- VRA 363.1K
- CRVO 476.7K
- Earning Date
- VRA 12-11-2024
- CRVO 11-12-2024
- Dividend Yield
- VRA N/A
- CRVO N/A
- EPS Growth
- VRA N/A
- CRVO N/A
- EPS
- VRA N/A
- CRVO N/A
- Revenue
- VRA $405,268,000.00
- CRVO $10,066,550.00
- Revenue This Year
- VRA N/A
- CRVO $34.17
- Revenue Next Year
- VRA $4.90
- CRVO N/A
- P/E Ratio
- VRA N/A
- CRVO N/A
- Revenue Growth
- VRA N/A
- CRVO 116.29
- 52 Week Low
- VRA $3.27
- CRVO $1.80
- 52 Week High
- VRA $8.32
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- VRA 40.52
- CRVO 28.45
- Support Level
- VRA $3.46
- CRVO $1.99
- Resistance Level
- VRA $3.97
- CRVO $2.43
- Average True Range (ATR)
- VRA 0.22
- CRVO 0.17
- MACD
- VRA 0.05
- CRVO 0.31
- Stochastic Oscillator
- VRA 54.88
- CRVO 26.92
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.